Health Insurers & Treatment Suppliers

Own the healthcare reimbursement chain: companies that finance patient care alongside established suppliers of medicines and medical devices. This pairs insurance underwriting and care-management businesses with commercial treatment franchises rather than concentrating on experimental drug development. The basket offers a different exposure from the fleet's drug-focused portfolios during the technology drawdown, although reimbursement pressure and medical-cost inflation remain shared risks. Launch basket (equal weight): UNH, MDT, JNJ, ABBV, AMGN, ELV, CI, HUM, CVS, ABT Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.